William J. Gibson, MD, PhD

William Gibson, MD, PhD, earned degrees in biological engineering and analytic philosophy at the Massachusetts Institute of Technology.  He then joined the Harvard-MIT MD/PhD program, where he conducted his thesis research with Rameen Beroukhim.  Dr. Gibson completed his residency in internal medicine at the Brigham and Women's Hospital and his Medical Oncology fellowship at Dana-Farber Cancer Institute.  He conducted post-doctoral research in the laboratories of Stuart Schreiber and Matthew Meyerson.  His research laboratory invents novel chemical biology technologies to address some of  cancer's most intractable problems, such as directly drugging TP53 mutant cancers.